XML 20 R10.htm IDEA: XBRL DOCUMENT
v3.21.1

Impairment and Credit Losses | 3 Months Ended
--- | ---
Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract] |
Impairment and Credit Losses | Note 3. Impairments and Credit Losses Starting in early 2020, the challenges related to COVID-19 have significantly impacted our expected investments, operating plans and projected cash flows. Refer to Note 1. General for further information regarding COVID-19 and its impact to the Company. As a result of these events, we performed interim impairment evaluations during 2020 on certain assets. During the quarter ended March 31, 2020, we recognized combined impairment and credit losses of $1.1 billion which are reported within Impairment and credit losses within our consolidated statements of comprehensive loss. The impairment losses of $1.1 billion were primarily related to our goodwill, trademarks and trade names, property and equipment, net and right-of-use assets. The credit losses of $38.1 million recognized during the quarter ended March 31, 2020 related to our notes receivable. In addition, an impairment charge of $39.7 million related to our equity investments was recognized in earnings during the quarter ended March 31, 2020 and is reported within Equity investment loss within our consolidated statements of comprehensive loss. For the quarter ended March 31, 2021, we had no indication of impairment or credit losses. The adverse impact COVID-19 will continue to have on our business, operating results, cash flows and overall financial condition is uncertain and may result in changes to the assumptions used in the impairment tests discussed above, which may result in additional impairments to these assets in the future.

X
- Definition The entire disclosure for the details of the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value. Disclosure may also include a description of the impaired asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired asset is reported. + References No definition available. + Details
Name: | us-gaap_AssetImpairmentChargesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration